KCG
GSK icon

Knight Capital Group’s GSK GSK Stock Holding History

Knight Capital Group’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$272K Buy
+4,350
New +$276K 0.01% 2354

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
FMI
Fiduciary Management Inc Milwaukee, Wisconsin $8.06B AUM 6.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Knight Capital Group's GSK Position: Q2 2013 in Review

Knight Capital Group opened a new position in GSK (GSK) in Q2 2013: 4,350 shares worth $272K. The stake represents 0.01% of the portfolio and ranks #2354 among its holdings.

639 funds tracked by Wall St. Rank hold GSK as of Q2 2013.

  • Knight Capital Group held 4,350 shares of GSK worth $272K as of Q2 2013.
  • GSK was a new Knight Capital Group position in Q2 2013.
  • GSK made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #2354 holding.
  • 639 funds tracked by Wall St. Rank held GSK as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.